Drug Profile
MSI 238
Latest Information Update: 20 Jun 2001
Price :
$50
*
At a glance
- Originator Genaera Corporation
- Developer Colgate-Palmolive; Genaera Corporation
- Class Amino acids; Antibacterials; Antineoplastics; Peptide antibiotics
- Mechanism of Action Protein synthesis inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Cancer; Periodontal disorders
Most Recent Events
- 20 Jun 2001 Discontinued-Preclinical for Cancer in USA (Unknown route)
- 20 Jun 2001 Discontinued-Preclinical for Periodontal disorders in USA (Unknown route)
- 14 Jul 1998 Profile reviewed